Skip to main content

Advertisement

Log in

Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Few observations on apheresis in pediatric nephrology units have been published.

Methods

This retrospective study involved children ≤18 years undergoing plasma exchange (PE), immunoadsorption (IA), or double filtration plasmapheresis (DFPP) in 12 European pediatric nephrology units during 2012.

Results

Sixty-seven children underwent PE, ten IA, and three DFPP, for a total of 738 PE and 349 IA/DFPP sessions; 67.2 % of PE and 69.2 % of IA/DFPP patients were treated for renal diseases, in particular focal segmental glomerulosclerosis (FSGS), hemolytic-uremic syndrome (HUS), and human leukocyte antigen (HLA) desensitization prior to renal transplantation; 20.9 % of PE and 23.1 % of IA/DFPP patients had neurological diseases. Membrane filtration was the most common technique, albumin the most frequently used substitution fluid, and heparin the preferred anticoagulant. PE achieved full disease remission in 25 patients (37.3 %), partial remission in 22 (32.8 %), and had no effect in 20 (29.9 %). The response to IA/DFPP was complete in seven patients (53.8 %), partial in five (38.5 %), and absent in one (7.7 %). Minor adverse events occurred during 6.9 % of PE and 9.7 % of IA/DFPP sessions.

Conclusions

PE, IA, and DFPP are safe apheresis methods in children. Efficacy is high in pediatric patients with recurrent focal segmental glomerulosclerosis (FSGS), atypical hemolytic uremic syndrome (HUS), human leukocyte antigen (HLA) sensitization, and neurological autoimmune diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Carter CE, Benador NM (2013) Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013. Pediatr Nephrol 29:35–50

    Article  PubMed  Google Scholar 

  2. Wong EC, Balogun RA (2012) Therapeutic apheresis in pediatrics: technique adjustments, indications and nonindications, a plasma exchange focus. J Clin Apher 27:132–137

    Article  PubMed  Google Scholar 

  3. Kim HC (2000) Therapeutic pediatric apheresis. J Clin Apher 15:129–157

    Article  CAS  PubMed  Google Scholar 

  4. Goldstein SL (2012) Therapeutic apheresis in children: special considerations. Semin Dial 25:165–170

    Article  PubMed  Google Scholar 

  5. De Palo T, Giordano M, Bellantuono R, Colella V, Troise D, Palumbo F, Caringella DA (2000) Therapeutic apheresis in children: experience in a pediatric dialysis center. Int J Artif Organs 23:834–839

    PubMed  Google Scholar 

  6. Kevy SV, Fosburg M (1990) Therapeutic apheresis in childhood. J Clin Apher 5:87–90

    CAS  PubMed  Google Scholar 

  7. Weiss PF, Klink AJ, Friedman DF, Feudtner C (2012) Pediatric therapeutic plasma exchange indications and patterns of use in US children’s hospitals. J Clin Apher 27:287–294

    Article  PubMed  Google Scholar 

  8. Witt V, Stegmayr B, Ptak J, Wikström B, Berlin G, Axelsson CG, Griskevicius A, Centoni PE, Liumbruno GM, Molfettini P, Audzijoniene J, Mokvist K, Sojka BN, Norda R, Ramlow W, Blaha M, Evergren M, Tomaz J (2008) World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry. Transfus Apher Sci 39:255–260

    Article  PubMed  Google Scholar 

  9. De Silvestro G, Tison T, Vicarioto M, Bagatella P, Stefanutti C, Marson P (2009) The Italian Registry of pediatric therapeutic apheresis: a report on activity during 2005. J Clin Apher 24:1–5

    Article  PubMed  Google Scholar 

  10. Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH (2013) Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 28:145–284

    Article  PubMed  Google Scholar 

  11. Raphaël JC, Chevret S, Hughes RA, Annane D (2012) Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 7, CD001798

    PubMed  Google Scholar 

  12. El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MM, Alwakeel AA, El-Tahan HM (2011) Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study. Crit Care 15:R164

    Article  PubMed Central  PubMed  Google Scholar 

  13. Dall’Amico R, Ghiggeri G, Carraro M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F (1999) Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34:1048–1055

    Article  PubMed  Google Scholar 

  14. Mahesh S, Del Rio M, Feuerstein D, Greenstein S, Schechner R, Tellis V, Kaskel F (2008) Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: a single center experience. Pediatr Transplant 12:682–688

    Article  PubMed  Google Scholar 

  15. Fuentes GM, Meseguer CG, Carrion AP, Hijosa MM, Garcia- Pose A, Melgar AA, Torres MN (2010) Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation. Pediatr Nephrol 25:529–534

    Article  PubMed  Google Scholar 

  16. Greenstein SM, Delrio M, Ong E, Feuerstein D, Schechner R, Kim D, Corey H, Kaskel R, Tellis VA, Moritz ML (2000) Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol 14:1061–1065

    Article  CAS  PubMed  Google Scholar 

  17. Schachter AD, Harmon WE (2001) Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children. Pediatr Transplant 5:406–409

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844–1859

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Pradhan M, Raffaelli RM, Lind C, Meyers KE, Kaplan BS, Baluarte HJ, Monos D (2008) Successful deceased donor renal transplant in a sensitized pediatric recipient with the use of plasmapheresis. Pediatr Transplant 12:711–716

    Article  PubMed  Google Scholar 

  20. Armangue T, Titulaer MJ, Málaga I, Bataller L, Gabilondo I, Graus F, Dalmau J; Spanish Anti-N-methyl-D-Aspartate Receptor (NMDAR) Encephalitis Work Group (2013) Pediatric Anti-N-methyl-D-Aspartate Receptor Encephalitis-Clinical Analysis and Novel Findings in a Series of 20 Patients. J Pediatr 162:850–856

  21. Paglialonga F, Ardissino G, Biasuzzi A, Testa S, Edefonti A (2012) Tandem plasma-exchange and haemodialysis in a paediatric dialysis unit. Pediatr Nephrol 27:493–495

    Article  PubMed  Google Scholar 

  22. Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, Schmitt CP (2011) Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Nephrol Dial Transplant 26:3633–3639

    Article  CAS  PubMed  Google Scholar 

  23. Michon B, Maghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, David M, Duval M, Hume HA, Robitaille N, Bélisle A, Champagne MA (2007) Complications of apheresis in children. Transfusion 47:1837–1842

    Article  PubMed  Google Scholar 

  24. Kara A, Turgut S, Cagli A, Sahin F, Oran E, Tunc B (2013) Complications of therapeutic apheresis in children. Transfus Apher Sci 48:375–376

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fabio Paglialonga.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paglialonga, F., Schmitt, C.P., Shroff, R. et al. Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units. Pediatr Nephrol 30, 103–111 (2015). https://doi.org/10.1007/s00467-014-2907-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-014-2907-3

Keywords

Navigation